Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Most of the world is aging demographically and while that has to be priced in to some degree, I think the benefit of developing new drugs and devices is pretty big. It may not be tomorrow, but China is aging quickly too. They spend a tiny amount per capita on healthcare compared to most of the world. Just imagine the opportunity if that many people start spending more on healthcare at a point in life when the need for healthcare generally increases anyway. I'm quite happy to keep buying the dips!
Comments